DXM, CYP2D6-inhibiting antidepressants, piracetam, and glutamine: proposing a ketamine-class antidepressant regimen with existing drugs
Rapid-acting antidepressants show that mood can lift within hours when glutamatergic circuits shift from an “NMDA-dominant” to an “AMPA-dominant” state. Intravenous ketamine achieves this flip but is hampered by dissociation and logistics, while dextromethorphan + bupropion (Auvelity®) primarily sup...
שמור ב:
| מחבר ראשי: | |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Frontiers Media S.A.
2026-03-01
|
| סדרה: | Frontiers in Psychiatry |
| נושאים: | |
| גישה מקוונת: | https://www.frontiersin.org/articles/10.3389/fpsyt.2026.1751605/full |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|